Article Category:
Case Report

Case Report: Tuberculosis-Induced Autoimmune Hemolytic Anemia

Seham M. Alebbi Department of Medical Education, Hamad Medical Corporation, Doha, Qatar;

Search for other papers by Seham M. Alebbi in
Current site
Google Scholar
PubMed Close
,
Aalaa Kambal Clinical Imaging Department, Hamad Medical Corporation, Doha, Qatar;

Search for other papers by Aalaa Kambal in
Current site
Google Scholar
PubMed Close
,
Hayan Abo Samra Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar;
Histopathology Department, Hamad Medical Corporation, Doha, Qatar;

Search for other papers by Hayan Abo Samra in
Current site
Google Scholar
PubMed Close
,
Mouhammad Z. Sharaf Eldean Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar;
Histopathology Department, Hamad Medical Corporation, Doha, Qatar;

Search for other papers by Mouhammad Z. Sharaf Eldean in
Current site
Google Scholar
PubMed Close
,
Shehab Fareed Mohamed Department of Hematology and Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar;

Search for other papers by Shehab Fareed Mohamed in
Current site
Google Scholar
PubMed Close
, and
Shaikha D. Al-Shokri Department of Medical Education, Hamad Medical Corporation, Doha, Qatar;
Department of Internal Medicine, Case Western Reserve University–MetroHealth Medical Center, Cleveland, Ohio

Search for other papers by Shaikha D. Al-Shokri in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.22-0217
Volume/Issue:
Volume 108: Issue 2
Page(s):
313–316
Restricted access
Get Permissions

ABSTRACT.

Tuberculosis (TB) is an infectious disease that affects different organs, causing multiple complications, including hematological sequelae. One of the most common TB-hematological complications is anemia of chronic disease. Very rarely autoimmune hemolytic anemia (AIHA) has been reported as an uncommon manifestation of TB. In this case, we present a female who presented with refractory AIHA, which was attributed to disseminated TB. The patient responded well to steroids, anti-TB medications, and rituximab.

Author Notes

Correspondence to Shaikha D. Al-Shokri, Department of Internal Medicine, Case Western Reserve University–MetroHealth Medical Center, 2500 Metrohealth Dr., Cleveland, OH 44109. E-mail: salshokri@hamad.qa

These authors contributed equally to this work.

Disclosure: This article was approved by Hamad Medical Corporation Medical Research Center. This research was conducted ethically in accordance with the World Medical Association Declaration of Helsinki.

Authors’ addresses: Seham M. Alebbi, Department of Medical Education, Hamad Medical Corporation, Doha, Qatar, E-mail: salebbi@hamad.qa. Aalaa Kambal, Clinical Imaging Department, Hamad Medical Corporation, Doha, Qatar, E-mail: akambal@hamad.qa. Hayan Abo Samra and Mouhammad Z. Sharaf Eldean, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Doha, Qatar, E-mails: hsamra@hamad.qa and meldean@hamad.qa. Shehab Fareed Mohamed, Department of Hematology and Medical Oncology, National Center for Cancer Care and Research, Hamad Medical Corporation, Doha, Qatar, E-mail smohamed22@hamad.qa. Shaikha D. Al-Shokri, Department of Medical Education, Hamad Medical Corporation, Doha, Qatar and Department of Internal Medicine, Case Western Reserve University–MetroHealth Medical Center, Cleveland, Ohio, E-mail: salshokri@hamad.qa.

Copyright:
© The American Society of Tropical Medicine and Hygiene 2023
Received:
22 Mar 2022
|
Accepted:
01 Sep 2022
|
Published Online:
19 Dec 2022
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Online ISSN:
1476-1645
  • 1.

    Gehrs BC, Friedberg RC, 2002. Autoimmune hemolytic anemia. Am J Hematol 69: 258–271.

  • 2.

    Sève P, Philippe P, Dufour JF, Broussolle C, Michel M, 2008. Autoimmune hemolytic anemia: classification and therapeutic approaches. Expert Rev Hematol 1: 189–204.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Coburn RJ, England JM, Samson DM, Walford DM, Blowers R, Chanarin I, Levi AJ, Slavin G, 1973. Tuberculosis and blood disorders. Br J Haematol 25: 793–799.

  • 4.

    Glasser RM, Walker RI, Walker RI, 1970. The significance of hematologic abnormalities in patients with tuberculosis. Arch Intern Med 125: 691–695.

  • 5.

    Cameron SJ, 1974. Tuberculosis and the blood—a special relationship? Tubercle 55: 55–72.

  • 6.

    Berkowitz FE, 1991. Hemolysis and infection: categories and mechanisms of their interrelationship. Rev Infect Dis 13: 1151–1162.

  • 7.

    Hill QA, Stamps R, Massey E, Grainger JD, Provan D, Hill A, 2017. The diagnosis and management of primary autoimmune hemolytic anaemia. Br J Haematol 176: 395–411.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8.

    Berentsen S, 2020. New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia. Front Immunol 11: 590.

  • 9.

    Berentsen S, Tjønnfjord GE, 2012. Diagnosis and treatment of cold agglutinin mediated autoimmune hemolytic anemia. Blood Rev 26: 107–115.

  • 10.

    Adigun R, Singh R, 2022. Tuberculosis. Tampa, FL: StatPearls Publishing [Internet]. PMID:28722945.

  • 11.

    Rathish D, Siribaddana S, 2018. Tuberculosis-induced autoimmune haemolytic anaemia: a systematic review to find out common clinical presentations, investigation findings and the treatment options. Allergy Asthma Clin Immunol 14: 11.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12.

    Shah M, Reed C, 2014. Complications of tuberculosis. Curr Opin Infect Dis 27: 403–410.

  • 13.

    Klein HG, Anstee DJ, 2014. Mollison’s Blood Transfusion in Clinical Medicine, 12th edition. New York, NY: John Wiley & Sons.

  • 14.

    Jäger U et al., 2020. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the First International Consensus Meeting. Blood Rev 41: 100648.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15.

    Hill QA, Stamps R, Massey E, Grainger JD, Provan D, Hill A, 2017. Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol 177: 208–220.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Petz LD, 1983. Autoimmune hemolytic anemia. Hum Pathol 14: 251–255.

  • 17.

    Dussadee K, Taka Bsc O, Thedsawad Msc A, Wanachiwanawin W, 2010. Incidence and risk factors of relapses in idiopathic autoimmune hemolytic anemia. J Med Assoc Thai 93 (Suppl 1): S165–S170.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18.

    Garvey B, 2008. Rituximab in the treatment of autoimmune haematological disorders. Br J Haematol 141: 149–169.

  • 19.

    Berentsen S, 2007. Rituximab for the treatment of autoimmune cytopenias. Haematologica 92: 1589–1596.

  • 20.

    Narat S, Gandla J, Hoffbrand AV, Hughes RG, Mehta AB, 2005. Rituximab in the treatment of refractory autoimmune cytopenias in adults. Haematologica 90: 1273–1274.

    • PubMed
    • Search Google Scholar
    • Export Citation
Past two years Past Year Past 30 Days
Abstract Views 5608 3302 96
Full Text Views 390 36 0
PDF Downloads 201 36 0
 

 

 

 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save